| Customization: | Available |
|---|---|
| Powder: | Yes |
| Certification: | GMP, HSE, ISO 9001, USP, BP |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Product Description:
Regorafenib Anhydrous Powder is pharmaceutical compound used in treatment of certain types of cancer. It belongs the class of multikinase inhibitors and is formulated as a dry powder.
Function:
Regorafenib Anhydrous Powder effectively inhibits multiple signaling pathways involved in tumor growth and angiogenesis. It has shown promising results in controlling the progression advanced colorectal cancer and gastrointestinal stromal tumors. Additionally its anti-angiogenic properties help to restrict blood supply to tumors.
Application:
Regorafenib Anhydrous Powder is primarily used in the pharmaceutical industry for the production of oral solid dosage forms, such as tablets and capsules. It is a key ingredient in the formulation of medication for the treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma. Its targeted mechanism of action makes it a valuable asset in targeted cancer therapies.
1. Are you a manufacturer or trading company?
A: We are a manufacturer and welcome to visit our factory.
){kind=link}